JK Agri Genetics Ltd approves Rs 19.80 crore leasehold transfer

JK Agri Genetics Ltd. has approved the transfer of leasehold rights over a non-operational 5.28-acre property in Telangana to Sai Life Sciences Limited for Rs 19.80 crore. The Board approved the transaction on 30 October 2026, with payment due by demand draft on completion and transfer expected within one month, subject to agreed terms and applicable approvals.

What asset is JK Agri Genetics transferring?

JK Agri Genetics is transferring leasehold rights in approximately 5.28 acres of non-operational immovable property, rather than selling a business division or operating undertaking. The Board's 30 October 2026 approval covers the property at IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Medchal-Malkajgiri District, Telangana.

The 5.28-acre leasehold asset generated no revenue or income during the last financial year, according to the disclosure. JK Agri Genetics reported its revenue or income contribution as Nil, distinguishing the land rights from an operating, revenue-producing unit.

The proposed transaction remains subject to terms agreed between the parties and to permissions from relevant authorities where applicable. JK Agri Genetics did not disclose a separate valuation, book value, tax treatment, or profit or loss from the Rs 19.80 crore transfer in its 30 October 2026 announcement.

How much will JK Agri Genetics receive and when?

JK Agri Genetics expects to receive total consideration of Rs 19.80 crore for the leasehold-rights transfer, payable by demand draft upon completion. The company said the transfer or assignment is expected to be completed within one month, subject to the transaction terms and any necessary approvals or permissions.

The disclosed Rs 19.80 crore consideration differs from the Nil revenue or income contribution reported for the last financial year. The Nil figure measures historic income from the 5.28-acre leasehold asset, whereas Rs 19.80 crore is the agreed amount for assigning the rights.

JK Agri Genetics has not said that it had received any part of the Rs 19.80 crore as of 30 October 2026. The demand draft mechanism links payment to completion of the transfer, and the filing does not specify an instalment schedule, advance payment, or a date within the one-month period for payment.

Why is JK Agri Genetics monetising the Telangana leasehold rights?

JK Agri Genetics said the Rs 19.80 crore transaction is intended to monetise the leasehold rights, strengthen cash flow and optimise financial resources. The stated rationale concerns a non-operational 5.28-acre asset that generated Nil revenue or income in the last financial year.

The change from Nil income to Rs 19.80 crore of proposed consideration reflects the mechanism disclosed by management: assigning a non-income-generating leasehold position for cash on completion. JK Agri Genetics did not provide a use-by-use allocation for the proceeds, such as debt repayment, capital expenditure, working capital, or shareholder distributions.

JK Agri Genetics also did not disclose a replacement property, agricultural project, or operating use for the 5.28-acre site after the assignment. Its 30 October 2026 filing identifies asset monetisation through a leasehold-rights transfer as the plan, with the expected one-month completion period as the next disclosed step.

Is the transfer a related-party deal or an undertaking disposal?

The transfer is not a related-party transaction and does not constitute disposal of an undertaking or substantially the whole of an undertaking, according to JK Agri Genetics. The company said Sai Life Sciences Limited is not part of its promoter group, promoter group companies, or related parties.

Sai Life Sciences Limited is described as a company incorporated under the Companies Act, 2013, operating in the contract research, development and manufacturing organisation sector and serving global pharmaceutical and biotechnology industries. JK Agri Genetics identifies it as buyer of the 5.28-acre leasehold rights for Rs 19.80 crore.

The transaction is outside a Scheme of Arrangement, JK Agri Genetics said. It stated that Regulation 37A of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations does not apply because the leasehold-rights transfer does not constitute an undertaking or substantially the whole of an undertaking under Section 180(1)(a) of the Companies Act, 2013.

JK Agri Genetics also marked the disclosure requirement for a slump sale as not applicable. That treatment supports the company's description of the Rs 19.80 crore transaction as an assignment of specific land leasehold rights rather than a transfer of an operating business.

Conclusion

JK Agri Genetics' 30 October 2026 approval sets out a proposed conversion of a non-operational 5.28-acre Telangana leasehold asset, which generated Nil income in the last financial year, into Rs 19.80 crore of consideration. The company frames the transaction as a cash-flow and financial-resource measure, while stating that it is neither a related-party transaction nor an undertaking disposal.

The next disclosed milestone is completion within one month and receipt of the Rs 19.80 crore demand draft. Completion remains subject to the parties' agreed terms and to any necessary permissions or approvals from relevant authorities.